EHang Reports First Quarter 2022 Unaudited Financial Results
31 mai 2022 06h34 HE
|
EHang Holdings Limited
Special Conditions for EH216-S Type Certification Formally Adopted by CAACNewly-Appointed Chief Operating Officer to Oversee Sales and OperationsIncreasing Number of Pre-Orders from More Asian Markets...
EHang and C.P. Group Form Strategic Partnership to Introduce Autonomous Aerial Vehicles to Thailand for Urban Air Mobility
27 mai 2022 07h27 HE
|
EHang Holdings Limited
GUANGZHOU, China, May 27, 2022 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading autonomous aerial vehicle (“AAV”) technology platform company,...
Ultragenyx Acquires Global Rights to AAV Gene Therapy ABO-102 for Sanfilippo Syndrome Type A (MPS IIIA) from Abeona Therapeutics
17 mai 2022 08h00 HE
|
Ultragenyx Pharmaceutical Inc.
ABO-102 / UX111 is being evaluated in ongoing pivotal Transpher A trial in patients with MPS IIIA Interim data featured in encore oral presentation at American Society of Gene & Cell Therapy...
Shape Therapeutics to Present Data Highlighting Advances in Its AI-Driven RNA Technology Platforms at the 2022 ASGCT Annual Meeting
12 mai 2022 08h00 HE
|
Shape Therapeutics, Inc.
SEATTLE, May 12, 2022 (GLOBE NEWSWIRE) -- Shape Therapeutics® Inc. the RNA technology company advancing programmable medicine, today announced new data from its RNAfix®, RNAskipTM and AAVidTM...
Freeline Reports First Quarter 2022 Financial Results and Business Highlights
10 mai 2022 16h01 HE
|
Freeline Therapeutics
Phase 1/2 clinical programs in Hemophilia B, Gaucher disease and Fabry disease on track to deliver 2022 milestones Recent appointment of new Chief Financial Officer further strengthens leadership...
Freeline Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 mai 2022 16h01 HE
|
Freeline Therapeutics
LONDON, May 03, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”) today announced that on April 29, 2022, the Company granted five newly hired...
Freeline To Present at the 25th Annual Meeting of the American Society of Gene and Cell Therapy
02 mai 2022 17h10 HE
|
Freeline Therapeutics
LONDON, May 02, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”) today announced the upcoming presentation of five posters at the 25th Annual...
Freeline Appoints Paul Schneider as Chief Financial Officer
19 avr. 2022 08h01 HE
|
Freeline Therapeutics
LONDON, April 19, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”) today announced that Paul M. Schneider has been appointed Chief Financial...
EHang Receives Pre-Order for 100 Units of EH216 AAVs from Indonesian Aviation Company Prestige Aviation
11 avr. 2022 06h36 HE
|
EHang Holdings Limited
GUANGZHOU, China, April 11, 2022 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world's leading autonomous aerial vehicle (“AAV”) technology platform...
Freeline Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 avr. 2022 16h01 HE
|
Freeline Therapeutics
LONDON, April 04, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”) today announced that on March 31, 2022, the Company granted its newly hired...